Inventor · disambiguated record
Lorin A. Thompson, Iii
Also filed as: THOMPSON III LORIN A · THOMPSON III LORIN ANDREW · THOMPSON LORIN A · THOMPSON LORIN ANDREW
40 granted patents·30 pending applications·424 citations·filing 1999–2024
98Inventor score
Files withBRISTOL MYERS SQUIBB CO34BRISTOL MYERS SQUIBB PHARMA CO14FULCRUM THERAPEUTICS INC11BOY KENNETH M4BRISTOL MEYERS SQUIBB CO1
Top patents by PatentIndex Score
70 records- 0195US7342008B2Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Mar 11, 2008·15 cites·30 claims
- 0294US10973805B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2020·Granted Apr 13, 2021·5 cites·20 claims
- 0394US8486952B2Compounds for the reduction of β-amyloid productionBOY KENNETH M·Filed 2010·Granted Jul 16, 2013·34 cites·15 claims
- 0494US7423033B2Hydroxyalkanoylaminolactams and related structures as inhibitors of aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2008·Granted Sep 9, 2008·13 cites·32 claims
- 0593US8637525B2Compounds for the reduction of beta-amyloid productionBOY KENNETH M·Filed 2011·Granted Jan 28, 2014·39 cites·5 claims
- 0691US11590111B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·2 cites·10 claims
- 0791US7101870B2Succinoylamino lactams as inhibitors of A-β protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2005·Granted Sep 5, 2006·13 cites·44 claims
- 0891US6962913B2Benzo-1,4-diazepin-2-ones as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 8, 2005·23 cites·31 claims
- 0989US9221796B2Selective NR2B antagonistsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 29, 2015·5 cites·12 claims
- 1089US9187506B2(R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one and its prodrugs for the treatment of psychiatric disordersBRISTOL MEYERS SQUIBB CO·Filed 2015·Granted Nov 17, 2015·5 cites·12 claims
- 1189US7304056B2Succinoylamino lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Dec 4, 2007·13 cites·9 claims
- 1289US7304055B2Succinoylamino lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Dec 4, 2007·13 cites·33 claims
- 1389US6503901B1Amino lactam sulfonamides as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Jan 7, 2003·23 cites·42 claims
- 1488US10342786B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·4 cites·19 claims
- 1588US6737038B1Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imagingBRISTOL MYERS SQUIBB CO·Filed 2000·Granted May 18, 2004·32 cites·16 claims
- 1687US7388007B2Gamma-lactams as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 17, 2008·6 cites·8 claims
- 1787US7112583B2Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Sep 26, 2006·13 cites·39 claims
- 1887US6960576B2Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 1, 2005·13 cites·54 claims
- 1987US6878363B2Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imagingBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Apr 12, 2005·20 cites·46 claims
- 2087US6503902B2Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jan 7, 2003·21 cites·47 claims
- 2186US10537560B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·4 cites·28 claims
- 2286US7902218B2Substituted tetrahydroisoquinolines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 8, 2011·5 cites·7 claims
- 2386US6794381B1Succinoylamino lactams as inhibitors of aβ proteinBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Sep 21, 2004·13 cites·22 claims
- 2483US2025195480A1Macrocyclic azolopyridine derivatives as eed and prc2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2582US6525044B2Succinoylamino carbocycles and heterocycles as inhibitors of a-β protein productionBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Feb 25, 2003·14 cites·18 claims
- 2681US12109198B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2022·Granted Oct 8, 2024·0 cites·5 claims
- 2781US6495540B2Lactams as inhibitors of A-β protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Dec 17, 2002·15 cites·18 claims
- 2880US7153491B2Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imagingBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Dec 26, 2006·16 cites·53 claims
- 2977US2023257743A1Use of p38 inhibitors to reduce expression of dux4FULCRUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3076US8349880B2Bicyclic compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jan 8, 2013·4 cites·6 claims
- 3176US7557137B2Gamma-lactams as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jul 7, 2009·9 cites·7 claims
- 3275US2022282254A1P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshdFULCRUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3374US2020297742A1(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one and its prodrugs for the treatment of psychiatric disordersBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 3473US2021121453A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 3572US2019314392A1(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one and its prodrugs for the treatment of psychiatric disordersBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 3672US2022133704A1P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshdFULCRUM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3771US8637523B2Compounds for the reduction of beta-amyloid productionBOY KENNETH M·Filed 2011·Granted Jan 28, 2014·2 cites·12 claims
- 3871US2019125770A1(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one and its prodrugs for the treatment of psychiatric disordersBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 3970US11479770B2Use of p38 inhibitors to reduce expression of DUX4FULCRUM THERAPEUTICS INC·Filed 2018·Granted Oct 25, 2022·0 cites·8 claims
- 4069US2020163949A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 4169US2018250316A1(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one and its prodrugs for the treatment of psychiatric disordersBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 4269US2019314358A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 4368US2019117638A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 4468US2018104265A1(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one and its prodrugs for the treatment of psychiatric disordersBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 4567US11291659B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2020·Granted Apr 5, 2022·0 cites·15 claims
- 4667US7507815B2Succinoylamino lactams as inhibitors of a-β protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Mar 24, 2009·0 cites·7 claims
- 4767US6331408B1Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide productionFiled 1999·Granted Dec 18, 2001·30 cites·58 claims
- 4867US2017340653A1(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one and its prodrugs for the treatment of psychiatric disordersBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 4966US2009111793A1Hydroxyalkanoylaminolactams and related structures as inhibitors of a beta protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2008·Application pending·0 cites
- 5066US2018250283A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lorin A. Thompson, Iii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →